Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Accounts of Chemical Research|August 21, 2007
Targeted cancer therapy: conferring specificity to cytotoxic drugsRavi V J ChariACS Medicinal Chemistry Letters|November 25, 2016
Expanding the Reach of Antibody-Drug ConjugatesRavi V J ChariClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody conjugate therapeutics: challenges and potentialBeverly A Teicher, Ravi V J ChariJournal of Medicinal Chemistry|June 27, 2014
Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancerJohn M Lambert, Ravi V J ChariAngewandte Chemie (International Ed. in English)|March 29, 2014
Antibody-drug conjugates: an emerging concept in cancer therapyRavi V J Chari, Michael L Miller, Wayne C WiddisonChemical Communications (Cambridge, England)|August 30, 2011
A novel pathway for maytansinoid release from thioether linked antibody-drug conjugates (ADCs) under oxidative conditionsNathan Fishkin, Erin K Maloney, Ravi V J Chari, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodiesMichael L Miller, Elizabeth E Roller, Xinyaun Wu, et al.Molecular Pharmaceutics|November 20, 2019
Antibody-Drug Conjugates with Indolinobenzodiazepine Dimer Payloads: DNA-Binding Mechanism of Indolinobenzodiazepine Dimer Catabolites in Target Cancer CellsRajeeva Singh, Emily E Reid, Luke Harris, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2004
Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumorsErkan Baloglu, Michael L Miller, Elizabeth E Roller, et al.Journal of Medicinal Chemistry|December 14, 2011
Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancerRobert Yongxin Zhao, Hans K Erickson, Barbara A Leece, et al.Pageof 3